IN VITRO CHARACTERIZATION OF CLOBAZAM METABOLISM BY RECOMBINANT CYTOCHROME P450 ENZYMES: IMPORTANCE OF CYP2C19 release_7hv44glmenddjbdzd3wwrb3qwq [as of editgroup_olkxqtu6njfstpsbq7xgg2s5hy]

by Carole Giraud, Agnès Tran, Elisabeth Rey, Jean Vincent, Jean-Marc Tréluyer, Gérard Pons

Published in Drug Metabolism And Disposition by American Society for Pharmacology & Experimental Therapeutics (ASPET)
ISSN-L 0090-9556
Volume 32
Issue 11
Page(s) 1279-1286
Release Date 2004-10-13
Publisher American Society for Pharmacology & Experimental Therapeutics (ASPET)
Primary Language en (lookup)
Type  article-journal
Stage   published
Date   2004-10-13
Container Metadata
Not Open Access
Not in DOAJ
ISSN-L:  0090-9556
Fatcat Entry
Work Entity
grouping other versions (eg, pre-print) and variants of this release
Cite This Release
Accepted Edit Version

This is the version of the entity as of a specific merged editgroup: olkxqtu6njfstpsbq7xgg2s5hy